Blood thinner safety after gastrointestinal bleeding
Part of Digestive system clinical trials.
This study looks at how to safely restart blood thinners after a major gastrointestinal bleed, specifically for people with atrial fibrillation or blood clots. It aims to find the best timing and approach to prevent future strokes or clots while avoiding another bleed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were hospitalized for a major gastrointestinal bleed while taking a direct oral anticoagulant (blood thinner).
- Your blood thinner was stopped because of this bleeding.
- You have atrial fibrillation (irregular heartbeat) with a moderate to high risk of stroke, or you have a history of blood clots (VTE).
- You do not have a mechanical heart valve, active gastrointestinal cancer, or a very low platelet count, and your kidney function is adequate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the safest time to restart a blood thinner after a traumatic brain bleed. You will be placed in one of two groups: one that restarts the medicine early (about 1 week after the injury) and another that restarts it later (about 4 weeks after).
This study tests whether taking a blood thinner after a stroke is safe and helpful for people who have atrial fibrillation (an irregular heartbeat) and have had a bleeding stroke in the past. It aims to prevent future strokes while managing the risk of another brain bleed.
This study compares whether you should temporarily stop your blood thinner (DOAC) or keep taking it when you have an elective heart catheter test or procedure (coronary angiography or PCI). It aims to see which approach is safer and better for preventing bleeding and clotting around the procedure.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
This trial looks at when it is safest to restart blood thinners after a traumatic brain bleed. It compares restarting at 4 weeks versus 8 weeks in people on blood thinners before their injury.
Hear when a new Gastrointestinal Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.